Compounds of the general formula (II):
and pharmaceutically acceptable salts and in-vivo hydrolysable esters thereof,
in which
R denotes a hydrogen atom or an in vivo hydrolysable acyl group;
and the wavy line denotes either the E- or Z-isomeric position,
are novel compounds which exhibit β-lactamase inhibitory action and have antibacterial properties.
通式(II)化合物:
及其药学上可接受的盐类和体内可水解的酯类、
其中
R 表示氢原子或体内可水解酰基;
波浪线表示 E-或 Z-异构体位置、
是具有β-内酰胺酶抑制作用和抗菌特性的新型化合物。
US4923856A
申请人:——
公开号:US4923856A
公开(公告)日:1990-05-08
US4931434A
申请人:——
公开号:US4931434A
公开(公告)日:1990-06-05
b-Lactamase Inhibitors: Synthesis and in vitro Evalution of 6-[(1-Substituted1,2,3-Triazol-4-yl)methylene]penicillanic Acid Sulfones
作者:Samarendra N. Maiti、Paul Eby、Maxwell D. Cummings、Oludotun A. Phillips、David P. Czajkowski、Maya P. Singh、Paul Spevak、Ronald G. Micetich